Language
Search
News
- Bruker Introduces Novel Fourier 300, a Compact, Easy-to-Use 300 MHz NMR
- Bruker Corporation Reports Record Financial Results for the Fourth Quarter and Full Year 2009
- Bruker Announces Over 100 Systems Orders Received in the Second Half of 2009 from Global Stimulus...
- Bruker Announces Framework Agreement for EPR e-scan™ Beer Analyzers to Enable New Levels of Quality...
- World’s First 1000 MHz NMR Spectrometer Now Offers New Research Capabilities to European...
Upcoming Events
Imaging
Non Invasive Technology for Preclinical, Molecular and Animal MR Imaging
Imaging based on magnetic resonance has revolutionized clinical diagnostics in the last decades. Preclinical MR imaging on small animals is increasingly used several biomedical and pharmaceutical applications from basic research to drug discovery. While in the 1990s the application focus was on rabbit to rat sized animals, the sequencing of the mice genome increased the interest in the investigation of mice. Molecular imaging is one of the latest upcoming fields that helps to investigate diseases at a molecular level.
Molecular imaging is aimed at detecting the origins of disease related pathways and targets by combining the use of molecular biomarkers.
Over the past decades magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) have shown enormous utility for research applications in the life sciences.
In materials research EPR imaging is of ten used to probe the generation and decomposition of free radicals in bulk polymer forms.